Media coverage about Danaher (NYSE:DHR) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Danaher earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the conglomerate an impact score of 46.3980188281578 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
These are some of the news stories that may have effected Accern’s scoring:
Danaher (NYSE DHR) traded up $0.07 on Friday, reaching $97.54. 1,889,022 shares of the company’s stock traded hands, compared to its average volume of 2,840,000. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39. The company has a market cap of $67,850.00, a PE ratio of 27.87, a P/E/G ratio of 2.05 and a beta of 1.04. Danaher has a 1-year low of $78.97 and a 1-year high of $104.82.
Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The business had revenue of $5.09 billion for the quarter, compared to analysts’ expectations of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The business’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.05 EPS. research analysts forecast that Danaher will post 4.37 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Friday, December 29th were paid a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 0.57%. The ex-dividend date was Thursday, December 28th. Danaher’s dividend payout ratio is currently 16.00%.
DHR has been the topic of a number of research reports. Morgan Stanley boosted their target price on shares of Danaher from $95.00 to $98.00 and gave the company an “overweight” rating in a report on Friday, October 20th. Credit Suisse Group boosted their target price on shares of Danaher from $93.00 to $96.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Robert W. Baird boosted their target price on shares of Danaher from $87.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Citigroup boosted their target price on shares of Danaher to $107.00 and gave the company a “buy” rating in a report on Friday, December 15th. Finally, Zacks Investment Research cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Danaher currently has an average rating of “Buy” and an average price target of $100.68.
In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the transaction, the senior vice president now owns 82,008 shares in the company, valued at approximately $8,388,598.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Daniel L. Comas sold 62,989 shares of the company’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the transaction, the chief financial officer now owns 227,805 shares in the company, valued at approximately $23,226,997.80. The disclosure for this sale can be found here. Insiders have sold a total of 237,043 shares of company stock worth $24,194,886 in the last 90 days. Company insiders own 12.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Danaher (DHR) Share Price” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/17/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-danaher-dhr-share-price.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.